Related Experiment Video
Updated: May 22, 2025

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Investigating Hearing Function in Paediatric Patients with Cancer in South Africa
Tlangelani Nyeleti Chauke1, Katijah Khoza-Shangase1
1Department of Audiology, School of Human and Community Development, University of the Witwatersrand, Johannesburg, South Africa.
Insights
Platinum-based chemotherapy causes hearing loss in children with cancer. In South Africa, limited resources hinder audiological monitoring, leading to untreated hearing impairments. Early detection is crucial for quality of life.
Area of Science:
- Ototoxic effects of cancer treatments on paediatric patients.
- Audiological assessment in resource-limited healthcare settings.
Background:
- Paediatric cancer patients on platinum-based chemotherapy face a high risk of ototoxicity and permanent hearing loss.
- Routine audiological monitoring is challenging in South Africa, risking undiagnosed hearing impairments.
Purpose of the Study:
- To investigate hearing function in paediatric cancer patients undergoing chemotherapy in South Africa.
- To assess the prevalence and characteristics of hearing loss associated with cancer treatment.
Main Methods:
- Retrospective review of audiological records from 47 paediatric cancer patients (ages 5-18).
- Analysis of hearing thresholds, tympanometry, and distortion-product otoacoustic emissions (DPOAE).
- Logistic regression to determine the association between cisplatin treatment and hearing loss.
Main Results:
- 36.2% of patients developed high-frequency sensorineural hearing loss post-treatment, with shifts at 4000-8000 Hz.
- Cisplatin treatment was significantly associated with hearing loss (OR=3.18, p=0.003).
- DPOAE confirmed outer hair cell dysfunction, indicating cochlear damage.
Conclusions:
- A significant proportion of South African paediatric cancer patients experience high-frequency hearing loss from ototoxic treatments.
- Standardized audiological monitoring protocols are essential, especially in resource-limited settings.
- Early detection and management can mitigate the impact of hearing loss on development and quality of life.
Abstract:
Paediatric cancer patients receiving platinum-based chemotherapy are at high risk of ototoxicity, often resulting in irreversible hearing loss. In South Africa, where healthcare resources are limited, routine audiological monitoring for this vulnerable population remains challenging, potentially leading to undiagnosed and untreated hearing impairments. To investigate hearing function in paediatric patients with cancer in South Africa. A descriptive, retrospective record review was conducted using patient data from two tertiary hospitals in Johannesburg: Chris Hani Baragwanath Academic Hospital and Charlotte Maxeke Johannesburg Academic Hospital. Audiological records for 47 paediatric cancer patients (ages 5-18) who had undergone baseline and follow-up hearing assessments were analysed. Descriptive and inferential statistics were used to examine hearing thresholds, tympanometry, and DPOAE results, with logistic regression assessing the association between cisplatin treatment and hearing loss. The study found that 36.2% of patients experienced high-frequency sensorineural hearing loss post-treatment, with significant threshold shifts at 4000-8000 Hz. Tympanometry indicated normal middle ear function in 87% of follow-up assessments, suggesting primarily cochlear damage. Logistic regression showed a significant association between cisplatin treatment and hearing loss, with an odds ratio of 3.18 (p = 0.003). DPOAE results further confirmed outer hair cell dysfunction, particularly in high frequencies, among patients who developed hearing loss. A substantial proportion of paediatric cancer patients in South Africa experience high-frequency hearing loss due to ototoxic treatments. These findings highlight the need for routine, standardized audiological monitoring protocols, particularly in resource-limited settings. Implementing early detection and management strategies can help mitigate the impact of hearing loss on language development, education, and quality of life in this vulnerable population.
Related Concept Videos
Hearing
The Cochlea

